NewsBot
01-Oct-16, 12:20
The Caithness Business Index (http://www.caithness-business.co.uk) has posted the following article:
New funding to support cutting-edge technology announced by the Chancellor
Philip Hammond has today (1 October 2016) unveiled a package of support which includes £220 million for the life science and university sectors to help technology breakthroughs translate into commercial success, as well as action to ensure disruptive businesses thrive in the UK. The package includes: * £100 million of funding to extend and enhance the Biomedical Catalyst, supporting innovative UK life science companies to translate cutting-edge medical technologies into commercial success * £120 million to incentivise university collaboration in tech transfer and in engaging with business, helping transform research at universities and institutions into viable business ventures * expanding the successful Challenger Business Programmes to address regulations that pose the largest barriers to the adoption of disruptive technologies The £100 million funding for the Biomedical Catalyst (BMC) will extend and enhance the programme for the next four years. [Read Full Article (http://caithness-business.co.uk/article.php?id=7024)]
New funding to support cutting-edge technology announced by the Chancellor
Philip Hammond has today (1 October 2016) unveiled a package of support which includes £220 million for the life science and university sectors to help technology breakthroughs translate into commercial success, as well as action to ensure disruptive businesses thrive in the UK. The package includes: * £100 million of funding to extend and enhance the Biomedical Catalyst, supporting innovative UK life science companies to translate cutting-edge medical technologies into commercial success * £120 million to incentivise university collaboration in tech transfer and in engaging with business, helping transform research at universities and institutions into viable business ventures * expanding the successful Challenger Business Programmes to address regulations that pose the largest barriers to the adoption of disruptive technologies The £100 million funding for the Biomedical Catalyst (BMC) will extend and enhance the programme for the next four years. [Read Full Article (http://caithness-business.co.uk/article.php?id=7024)]